Who Owns Neosporin?

Neosporin operates under Kenvue's corporate sustainability framework. Kenvue publishes an annual ESG report covering environmental impact, social responsibility, and governance across its brand portfolio.

Packaging: Kenvue has committed to making 100% of its packaging recyclable or reusable by 2030. Neosporin tubes and cartons are part of this initiative. However, the small size of ointment tubes makes recycling challenging, and many tubes end up in landfills. Kenvue does not break out brand-specific packaging metrics for Neosporin.

No Brand-Specific Sustainability Data: Kenvue does not publish carbon footprint data, water usage, or waste diversion rates specific to the Neosporin brand. Sustainability data is reported at the corporate level, not by individual product line.

Product Safety: As an FDA-regulated OTC drug product, Neosporin is subject to strict safety and quality standards including current Good Manufacturing Practices (cGMP). Kenvue must maintain FDA registration for its manufacturing facilities and report any adverse events through the FDA's MedWatch program.

Antibiotic Stewardship: The broader medical community has raised concerns about the routine use of OTC antibiotic ointments for minor wounds. Some dermatologists argue that plain petrolatum or Aquaphor is equally effective for most minor cuts and scrapes, and that widespread use of antibiotic ointments may contribute to antibiotic resistance and allergic contact dermatitis. Kenvue has not publicly addressed these concerns specifically for Neosporin, but the introduction of Simply Neosporin (without neomycin) may be a partial response to allergy concerns.

• Pharmacy Times Survey: Neosporin has been consistently recognized by pharmacists in Pharmacy Times surveys as one of the most recommended antibiotic ointment brands for over-the-counter wound care. This is a publicly verifiable recognition based on pharmacist surveys.
• #1 Doctor-Recommended Brand: Neosporin's marketing claims the brand is the #1 doctor-recommended first aid antibiotic ointment. This claim is based on physician surveys conducted by the brand.

Beyond these recognitions, Neosporin does not have a significant awards profile. The brand's recognition comes from its decades-long presence in American households and its status as a staple in first aid kits. Some previous versions of this page listed generic awards (e.g., "Consumer Reports Rankings") that cannot be specifically verified for Neosporin as a standalone brand.

Allergic Contact Dermatitis: Neomycin, one of the three active ingredients in Neosporin Original, is a known allergen. The American Contact Dermatitis Society named neomycin as the "Allergen of the Year" in 2010 due to the high rate of allergic contact dermatitis associated with its use. Some users develop allergic reactions to neomycin, which can cause redness, itching, and swelling at the application site. Kenvue offers Simply Neosporin (without neomycin) as an alternative for consumers with neomycin sensitivity.

Antibiotic Resistance Concerns: There is an ongoing debate in the medical community about whether OTC antibiotic ointments like Neosporin contribute to antibiotic resistance. Some healthcare professionals argue that antibiotic ointments are overused for minor wounds that would heal without them. The CDC has published guidance on appropriate antibiotic use, though it does not specifically target OTC topical antibiotics. This concern could affect long-term demand for the product category.

No Major Recalls: There have been no major FDA recalls of Neosporin products. FDA recall databases do not list Neosporin as a recalled product. This reflects the brand's long safety record and the standardized nature of the OTC monograph formula.

J&J to Kenvue Transition: The 2023 spin-off of Neosporin from Johnson & Johnson to Kenvue was a major corporate event but did not involve any product changes. The formula, packaging, and regulatory status remained the same. Some consumers may not be aware that the brand changed ownership, as the Neosporin name and packaging remained consistent through the transition.